The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine

E Rubinstein, G Predy, L Sauvé, GW Hammond, F Aoki… - Cmaj, 2011 - Can Med Assoc
Background: Because many Aboriginal Canadians had severe cases of pandemic (H1N1)
2009 influenza, they were given priority access to vaccine. However, it was not known if the …

[HTML][HTML] Factors influencing H1N1 vaccine behavior among Manitoba Metis in Canada: a qualitative study

SM Driedger, R Maier, C Furgal, C Jardine - BMC public health, 2015 - Springer
Background During the first wave of the H1N1 influenza pandemic in 2009, Aboriginal
populations in Canada experienced disproportionate rates of infection, particularly in the …

Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trial

DW Scheifele, BJ Ward, M Dionne, OG Vanderkooi… - Vaccine, 2012 - Elsevier
When Canada chose a novel adjuvanted vaccine to combat the 2009 influenza pandemic,
seasonal trivalent inactivated vaccine (TIV) was also available but compatibility of the two …

[HTML][HTML] Why is influenza vaccine uptake so low among Aboriginal adults?

R Menzies, J Aqel, I Abdi, T Joseph, H Seale… - Australian and New …, 2020 - Elsevier
Objectives: Determine major barriers to, and facilitators of, influenza vaccination of
Aboriginal adults, in order to improve coverage from the current level of 30%. Methods: i) A …

[HTML][HTML] A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an …

TN Duong, VD Thiem, DD Anh, NP Cuong, TC Thang… - Vaccine, 2020 - Elsevier
Background A global shortfall of vaccines for avian influenza A (H5N1) would occur,
especially in low-and-middle income countries, if a pandemic were to occur. To address this …

Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec …

I Rouleau, G De Serres, DM Skowronski, JP Drolet… - Vaccine, 2014 - Elsevier
Abstract Introduction In Quebec, Canada, receipt of the 2009 AS03-adjuvanted pandemic
H1N1 vaccine was associated with increased risk of anaphylaxis and other allergic-like …

Safety, reactogenicity, and immunogenicity of inactivated monovalent influenza A (H5N1) virus vaccine administered with or without AS03 adjuvant

WH Chen, LA Jackson, KM Edwards… - Open forum …, 2014 - academic.oup.com
Background. The national stockpile for influenza pandemic preparedness includes vaccines
against an array of strains and adjuvants that could be utilized to induce immunologic …

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials

E Plennevaux, E Sheldon, M Blatter… - The Lancet, 2010 - thelancet.com
Background Data are needed from large clinical trials of paediatric, adult, and elderly people
to find the appropriate antigen dose and vaccination schedule for the 2009 pandemic …

[HTML][HTML] Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals

D Kelly, K Burt, B Missaghi, L Barrett, Y Keynan… - BMC immunology, 2012 - Springer
Background Influenza infection may be more serious in human immunodeficiency virus
(HIV)-infected individuals, therefore, vaccination against seasonal and pandemic strains is …

[HTML][HTML] Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults

P Gillard, DWS Chu, SJ Hwang, PC Yang… - BMC infectious …, 2014 - Springer
Background The pandemic potential of avian influenza A/H5N1 should not be overlooked,
and the continued development of vaccines against these highly pathogenic viruses is a …